Thomas C. Chamberlain

414 total citations
8 papers, 292 citations indexed

About

Thomas C. Chamberlain is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Thomas C. Chamberlain has authored 8 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Thomas C. Chamberlain's work include Circular RNAs in diseases (2 papers), MicroRNA in disease regulation (2 papers) and Cancer therapeutics and mechanisms (1 paper). Thomas C. Chamberlain is often cited by papers focused on Circular RNAs in diseases (2 papers), MicroRNA in disease regulation (2 papers) and Cancer therapeutics and mechanisms (1 paper). Thomas C. Chamberlain collaborates with scholars based in Canada, Australia and United Kingdom. Thomas C. Chamberlain's co-authors include Alice Mui, Jonathan P. Little, Hashim Islam, David Jamieson, Alan V. Boddy, Christopher Hill, Julieann Sludden, Julie Errington, Gareth J. Veal and Girish Chinnaswamy and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Thomas C. Chamberlain

7 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas C. Chamberlain Canada	7	77	69	59	51	51	8	292
Elham Rajaei Iran	11	70 0.9×	69 1.0×	27 0.5×	32 0.6×	57 1.1×	37	366
Falk A. Gonnert Germany	12	159 2.1×	72 1.0×	54 0.9×	60 1.2×	111 2.2×	20	499
Danyi Zeng China	10	49 0.6×	54 0.8×	23 0.4×	42 0.8×	16 0.3×	16	299
Qingjing Zhu China	10	135 1.8×	133 1.9×	31 0.5×	50 1.0×	20 0.4×	16	429
Juping Du China	9	140 1.8×	123 1.8×	17 0.3×	60 1.2×	42 0.8×	10	353
Shuyi Han China	10	161 2.1×	46 0.7×	18 0.3×	42 0.8×	38 0.7×	15	358
Luz María Torres‐Espíndola Mexico	9	120 1.6×	22 0.3×	18 0.3×	69 1.4×	43 0.8×	34	323
Peidong Zhang China	9	79 1.0×	94 1.4×	10 0.2×	42 0.8×	69 1.4×	28	331
Yanjiao Lu China	11	98 1.3×	54 0.8×	10 0.2×	34 0.7×	59 1.2×	22	314

Countries citing papers authored by Thomas C. Chamberlain

Since Specialization

Citations

This map shows the geographic impact of Thomas C. Chamberlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Chamberlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Chamberlain more than expected).

Fields of papers citing papers by Thomas C. Chamberlain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Chamberlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Chamberlain. The network helps show where Thomas C. Chamberlain may publish in the future.

Co-authorship network of co-authors of Thomas C. Chamberlain

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Chamberlain. A scholar is included among the top collaborators of Thomas C. Chamberlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Chamberlain. Thomas C. Chamberlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Chamberlain, Thomas C., et al.. (2025). The regulation of miR-155 strand selection by CELF2, FUBP1 and KSRP proteins. Scientific Reports. 15(1). 30217–30217.

2.

Islam, Hashim, Thomas C. Chamberlain, Alice Mui, & Jonathan P. Little. (2021). Elevated Interleukin-10 Levels in COVID-19: Potentiation of Pro-Inflammatory Responses or Impaired Anti-Inflammatory Action?. Frontiers in Immunology. 12. 677008–677008. 117 indexed citations

3.

Chamberlain, Thomas C., Andrew Ming‐Lum, Edis Dzananovic, et al.. (2020). Interleukin-10 and Small Molecule SHIP1 Allosteric Regulators Trigger Anti-inflammatory Effects through SHIP1/STAT3 Complexes. iScience. 23(8). 101433–101433. 22 indexed citations

4.

Chamberlain, Thomas C., et al.. (2020). Interleukin-10 contributes to PGE2 signalling through upregulation of EP4 via SHIP1 and STAT3. PLoS ONE. 15(4). e0230427–e0230427. 15 indexed citations

5.

Zhu, Tian Hao, et al.. (2020). Interleukin-10 control of pre-miR155 maturation involves CELF2. PLoS ONE. 15(4). e0231639–e0231639. 7 indexed citations

6.

Ong, Christopher J., et al.. (2020). Interleukin-10 Induces Expression of Neuroendocrine Markers and PDL1 in Prostate Cancer Cells. SHILAP Revista de lepidopterología. 2020. 1–12. 15 indexed citations

7.

Nicoletti, Paola, Guruprasad P. Aithal, Thomas C. Chamberlain, et al.. (2019). Drug‐Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles. Clinical Pharmacology & Therapeutics. 106(1). 245–253. 66 indexed citations

8.

Veal, Gareth J., Michael Cole, Girish Chinnaswamy, et al.. (2016). Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma. European Journal of Cancer. 55. 56–64. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact